Published in Curr Alzheimer Res on January 01, 2016
Photoreceptor protection via blockade of BET epigenetic readers in a murine model of inherited retinal degeneration. J Neuroinflammation (2017) 0.79
Emerging Epigenetic Therapies in Neuroscience: Focus on Bromodomain-Containing Drug Targets. Neuropsychopharmacology (2017) 0.75
Bromodomains in Protozoan Parasites: Evolution, Function, and Opportunities for Drug Development. Microbiol Mol Biol Rev (2017) 0.75
Epigenetic intervention with a BET inhibitor ameliorates acute retinal ganglion cell death in mice. Mol Vis (2017) 0.75
The BET/BRD inhibitor JQ1 improves brain plasticity in WT and APP mice. Transl Psychiatry (2017) 0.75
The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol (2004) 19.38
Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction. Neuron (2003) 14.03
TREM2 variants in Alzheimer's disease. N Engl J Med (2012) 11.35
Suppression of inflammation by a synthetic histone mimic. Nature (2010) 8.80
Physiology of microglia. Physiol Rev (2011) 6.99
Control of inducible gene expression by signal-dependent transcriptional elongation. Cell (2009) 6.57
Intraneuronal Abeta causes the onset of early Alzheimer's disease-related cognitive deficits in transgenic mice. Neuron (2005) 6.20
Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model. Neuron (2007) 6.07
Alzheimer's disease. Lancet (2011) 5.35
Annual incidence of Alzheimer disease in the United States projected to the years 2000 through 2050. Alzheimer Dis Assoc Disord (2001) 5.09
Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: a review of 17 epidemiologic studies. Neurology (1996) 4.42
Brd4 coactivates transcriptional activation of NF-kappaB via specific binding to acetylated RelA. Mol Cell Biol (2008) 3.74
Tangle and neuron numbers, but not amyloid load, predict cognitive status in Alzheimer's disease. Neurology (2003) 3.62
Alzheimer's disease risk gene CD33 inhibits microglial uptake of amyloid beta. Neuron (2013) 3.43
Lipopolysaccharide-induced inflammation exacerbates tau pathology by a cyclin-dependent kinase 5-mediated pathway in a transgenic model of Alzheimer's disease. J Neurosci (2005) 3.18
An English translation of Alzheimer's 1907 paper, "Uber eine eigenartige Erkankung der Hirnrinde". Clin Anat (1995) 3.07
Neuroinflammation in Alzheimer's disease. Lancet Neurol (2015) 3.02
beta-amyloid fibrils induce tau phosphorylation and loss of microtubule binding. Neuron (1995) 2.56
CD33 Alzheimer's disease locus: altered monocyte function and amyloid biology. Nat Neurosci (2013) 2.51
Interleukin-1 expression in different plaque types in Alzheimer's disease: significance in plaque evolution. J Neuropathol Exp Neurol (1995) 2.35
Interleukin-1 mediates pathological effects of microglia on tau phosphorylation and on synaptophysin synthesis in cortical neurons through a p38-MAPK pathway. J Neurosci (2003) 2.35
Moderate reduction of gamma-secretase attenuates amyloid burden and limits mechanism-based liabilities. J Neurosci (2007) 2.31
Regulation of tau pathology by the microglial fractalkine receptor. Neuron (2010) 2.24
Inverse association of anti-inflammatory treatments and Alzheimer's disease: initial results of a co-twin control study. Neurology (1994) 2.04
The role of interleukin-1 in neuroinflammation and Alzheimer disease: an evolving perspective. J Neuroinflammation (2008) 2.03
Progesterone and estrogen regulate Alzheimer-like neuropathology in female 3xTg-AD mice. J Neurosci (2007) 2.00
Selective targeting of perivascular macrophages for clearance of beta-amyloid in cerebral amyloid angiopathy. Proc Natl Acad Sci U S A (2009) 1.83
BET protein function is required for inflammation: Brd2 genetic disruption and BET inhibitor JQ1 impair mouse macrophage inflammatory responses. J Immunol (2013) 1.74
Inflammatory repertoire of Alzheimer's disease and nondemented elderly microglia in vitro. Glia (2001) 1.53
Cyclooxygenase-2 inhibition improves amyloid-beta-mediated suppression of memory and synaptic plasticity. Brain (2008) 1.42
Protection from Alzheimer's-like disease in the mouse by genetic ablation of inducible nitric oxide synthase. J Exp Med (2005) 1.40
Blocking IL-1 signaling rescues cognition, attenuates tau pathology, and restores neuronal β-catenin pathway function in an Alzheimer's disease model. J Immunol (2011) 1.36
RVX-208, an inhibitor of BET transcriptional regulators with selectivity for the second bromodomain. Proc Natl Acad Sci U S A (2013) 1.35
BET bromodomain inhibition suppresses TH17-mediated pathology. J Exp Med (2013) 1.33
Cyclooxygenase expression in microglia and neurons in Alzheimer's disease and control brain. Acta Neuropathol (2001) 1.30
Age-dependent sexual dimorphism in cognition and stress response in the 3xTg-AD mice. Neurobiol Dis (2007) 1.30
Inducible nitric oxide synthase in tangle-bearing neurons of patients with Alzheimer's disease. J Exp Med (1996) 1.25
Interleukin-1 beta induces prostaglandin G/H synthase-2 (cyclooxygenase-2) in primary murine astrocyte cultures. J Neurochem (1996) 1.24
Neuronal cyclooxygenase 2 expression in the hippocampal formation as a function of the clinical progression of Alzheimer disease. Arch Neurol (2001) 1.17
BET protein Brd4 activates transcription in neurons and BET inhibitor Jq1 blocks memory in mice. Nat Neurosci (2015) 1.17
Inflammatory cytokine levels correlate with amyloid load in transgenic mouse models of Alzheimer's disease. J Neuroinflammation (2005) 1.16
Modeling microglial activation in Alzheimer's disease with human postmortem microglial cultures. Neurobiol Aging (2001) 1.15
Levels of CSF prostaglandin E2, cognitive decline, and survival in Alzheimer's disease. J Neurol Neurosurg Psychiatry (2005) 1.15
Polymorphisms in inflammatory genes and the risk of Alzheimer disease. Arch Neurol (2001) 1.13
Amyloid-beta-induced chemokine production in primary human macrophages and astrocytes. J Neuroimmunol (2002) 1.08
Asymptomatic Alzheimer's disease: a prodrome or a state of resilience? Curr Alzheimer Res (2011) 1.05
Lower oxidative DNA damage despite greater ROS production in muscles from rats selectively bred for high running capacity. Am J Physiol Regul Integr Comp Physiol (2010) 1.05
Assessment of spatial learning abilities of mice in a new circular maze. Physiol Behav (2003) 1.05
Presenilin-1 mutations reduce cytoskeletal association, deregulate neurite growth, and potentiate neuronal dystrophy and tau phosphorylation. J Neurosci (2001) 1.01
NSAIDS inhibit the IL-1 beta-induced IL-6 release from human post-mortem astrocytes: the involvement of prostaglandin E2. Brain Res (1997) 1.01
Cognitive and non-cognitive behaviors in the triple transgenic mouse model of Alzheimer's disease expressing mutated APP, PS1, and Mapt (3xTg-AD). Behav Brain Res (2012) 1.00
BET bromodomain proteins are required for glioblastoma cell proliferation. Epigenetics (2014) 0.99
BET protein inhibition shows efficacy against JAK2V617F-driven neoplasms. Leukemia (2013) 0.97
Myeloproliferative disease in mice with reduced presenilin gene dosage: effect of gamma-secretase blockage. Biochemistry (2004) 0.97
Epigenetic Readers of Lysine Acetylation Regulate Cocaine-Induced Plasticity. J Neurosci (2015) 0.96
Phosphorylation of tau protein at sites Ser(396-404) is one of the earliest events in Alzheimer's disease and Down syndrome. Neuropathol Appl Neurobiol (2014) 0.94
Expression of non-protein-coding antisense RNAs in genomic regions related to autism spectrum disorders. Mol Autism (2013) 0.88
A complex proinflammatory role for peripheral monocytes in Alzheimer's disease. J Alzheimers Dis (2014) 0.88
Interleukin-1 beta uses common and distinct signaling pathways for induction of the interleukin-6 and tumor necrosis factor alpha genes in the human astrocytoma cell line U373. J Neurochem (1996) 0.84
Autoimmune manifestations in the 3xTg-AD model of Alzheimer's disease. J Alzheimers Dis (2014) 0.83
Antisense RNA controls LRP1 Sense transcript expression through interaction with a chromatin-associated protein, HMGB2. Cell Rep (2015) 0.82
Small RNA-directed transcriptional control: new insights into mechanisms and therapeutic applications. Cell Cycle (2010) 0.82
RNA sequencing reveals distinct mechanisms underlying BET inhibitor JQ1-mediated modulation of the LPS-induced activation of BV-2 microglial cells. J Neuroinflammation (2015) 0.82
Transcriptomics Profiling of Alzheimer's Disease Reveal Neurovascular Defects, Altered Amyloid-β Homeostasis, and Deregulated Expression of Long Noncoding RNAs. J Alzheimers Dis (2015) 0.79
New pathway links γ-secretase to inflammation and memory while sparing notch. Ann Neurol (2011) 0.76
Genome-wide analysis of mammalian promoter architecture and evolution. Nat Genet (2006) 17.19
The transcriptional network that controls growth arrest and differentiation in a human myeloid leukemia cell line. Nat Genet (2009) 6.02
Expression of a noncoding RNA is elevated in Alzheimer's disease and drives rapid feed-forward regulation of beta-secretase. Nat Med (2008) 5.62
Myogenic gene expression signature establishes that brown and white adipocytes originate from distinct cell lineages. Proc Natl Acad Sci U S A (2007) 4.69
Regulatory roles of natural antisense transcripts. Nat Rev Mol Cell Biol (2009) 4.48
Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model. Proc Natl Acad Sci U S A (2002) 4.20
Complex Loci in human and mouse genomes. PLoS Genet (2006) 3.74
The reality of pervasive transcription. PLoS Biol (2011) 3.41
Inhibition of natural antisense transcripts in vivo results in gene-specific transcriptional upregulation. Nat Biotechnol (2012) 3.07
RNAdb--a comprehensive mammalian noncoding RNA database. Nucleic Acids Res (2005) 2.84
Using molecular classification to predict gains in maximal aerobic capacity following endurance exercise training in humans. J Appl Physiol (1985) (2010) 2.74
Striatal microRNA controls cocaine intake through CREB signalling. Nature (2010) 2.56
A systematic analysis of the silencing effects of an active siRNA at all single-nucleotide mismatched target sites. Nucleic Acids Res (2005) 2.27
Locked nucleic acid (LNA) mediated improvements in siRNA stability and functionality. Nucleic Acids Res (2005) 2.20
Evidence for natural antisense transcript-mediated inhibition of microRNA function. Genome Biol (2010) 2.08
MicroRNA-219 modulates NMDA receptor-mediated neurobehavioral dysfunction. Proc Natl Acad Sci U S A (2009) 2.00
Considerations when using the significance analysis of microarrays (SAM) algorithm. BMC Bioinformatics (2005) 1.89
Human muscle gene expression responses to endurance training provide a novel perspective on Duchenne muscular dystrophy. FASEB J (2005) 1.85
A small molecule enhances RNA interference and promotes microRNA processing. Nat Biotechnol (2008) 1.80
Lateral hypothalamic orexin/hypocretin neurons: A role in reward-seeking and addiction. Brain Res (2009) 1.79
Amygdala-dependent fear is regulated by Oprl1 in mice and humans with PTSD. Sci Transl Med (2013) 1.74
Integration of microRNA changes in vivo identifies novel molecular features of muscle insulin resistance in type 2 diabetes. Genome Med (2010) 1.64
Improved and automated prediction of effective siRNA. Biochem Biophys Res Commun (2004) 1.58
A novel RNA transcript with antiapoptotic function is silenced in fragile X syndrome. PLoS One (2008) 1.57
Promoter-specific transcriptional interference and c-myc gene silencing by siRNAs in human cells. EMBO J (2009) 1.55
Role of orexin/hypocretin in reward-seeking and addiction: implications for obesity. Physiol Behav (2010) 1.50
MicroRNA-132 dysregulation in schizophrenia has implications for both neurodevelopment and adult brain function. Proc Natl Acad Sci U S A (2012) 1.49
Pseudo-messenger RNA: phantoms of the transcriptome. PLoS Genet (2006) 1.46
Regulation of chromatin structure by long noncoding RNAs: focus on natural antisense transcripts. Trends Genet (2012) 1.46
Single nucleotide polymorphisms in the proximal promoter region of the adiponectin (APM1) gene are associated with type 2 diabetes in Swedish caucasians. Diabetes (2004) 1.41
MicroRNA dysregulation in psychiatric disease. Brain Res (2010) 1.34
Apoptosis resistance downstream of eIF4E: posttranscriptional activation of an anti-apoptotic transcript carrying a consensus hairpin structure. Nucleic Acids Res (2006) 1.27
Noncoding RNAs: couplers of analog and digital information in nervous system function? Trends Neurosci (2007) 1.27
Intronic RNAs constitute the major fraction of the non-coding RNA in mammalian cells. BMC Genomics (2012) 1.26
Multiple roles for orexin/hypocretin in addiction. Prog Brain Res (2012) 1.26
RNA interference is not involved in natural antisense mediated regulation of gene expression in mammals. Genome Biol (2006) 1.21
Altered regulation of the PINK1 locus: a link between type 2 diabetes and neurodegeneration? FASEB J (2007) 1.19
Expression profiling following local muscle inactivity in humans provides new perspective on diabetes-related genes. Genomics (2005) 1.18
microRNAs in CNS disorders. Neuromolecular Med (2009) 1.17
Analysis of siRNA specificity on targets with double-nucleotide mismatches. Nucleic Acids Res (2008) 1.14
Validating siRNA using a reporter made from synthetic DNA oligonucleotides. Biochem Biophys Res Commun (2004) 1.14
Therapeutic potential of neuropeptide Y (NPY) receptor ligands. EMBO Mol Med (2010) 1.12
NotI subtraction and NotI-specific microarrays to detect copy number and methylation changes in whole genomes. Proc Natl Acad Sci U S A (2002) 1.10
Small GTP-binding protein Rac is an essential mediator of vascular endothelial growth factor-induced endothelial fenestrations and vascular permeability. Circulation (2003) 1.10
The human PINK1 locus is regulated in vivo by a non-coding natural antisense RNA during modulation of mitochondrial function. BMC Genomics (2007) 1.10
Personalized medicine in psychiatry: problems and promises. BMC Med (2013) 1.09
Activity-induced and developmental downregulation of the Nogo receptor. Cell Tissue Res (2003) 1.07
Kinetics of senescence-associated changes of gene expression in an epithelial, temperature-sensitive SV40 large T antigen model. Cancer Res (2004) 1.07
Identification of functional SNPs in the 5-prime flanking sequences of human genes. BMC Genomics (2005) 1.07
Effective small interfering RNAs and phosphorothioate antisense DNAs have different preferences for target sites in the luciferase mRNAs. Biochem Biophys Res Commun (2003) 1.06
A new approach to genome mapping and sequencing: slalom libraries. Nucleic Acids Res (2002) 1.05
Decreased cerebrospinal fluid neuropeptide Y (NPY) in patients with treatment refractory unipolar major depression: preliminary evidence for association with preproNPY gene polymorphism. J Psychiatr Res (2004) 1.04
Involvement of long noncoding RNAs in diseases affecting the central nervous system. RNA Biol (2012) 1.04
The expression signature of in vitro senescence resembles mouse but not human aging. Genome Biol (2005) 1.03
Platelets activated during myocardial infarction release functional miRNA, which can be taken up by endothelial cells and regulate ICAM1 expression. Blood (2013) 1.03
Selective antihypertensive dihydropyridines lower Aβ accumulation by targeting both the production and the clearance of Aβ across the blood-brain barrier. Mol Med (2010) 0.98
Selective and brain penetrant neuropeptide y y2 receptor antagonists discovered by whole-cell high-throughput screening. Mol Pharmacol (2009) 0.98
Modulation of the activity of Sp transcription factors by mithramycin analogues as a new strategy for treatment of metastatic prostate cancer. PLoS One (2012) 0.97
Non-coding RNA transcripts: sensors of neuronal stress, modulators of synaptic plasticity, and agents of change in the onset of Alzheimer's disease. Neurosci Lett (2009) 0.96
hUNC93B1: a novel human gene representing a new gene family and encoding an unc-93-like protein. Gene (2002) 0.96
Epigenetic mechanisms of gene regulation during mammalian spermatogenesis. Epigenetics (2008) 0.95
RNA Interference with chemically modified siRNA. Curr Top Med Chem (2006) 0.93
Human neuropeptide Y signal peptide gain-of-function polymorphism is associated with increased body mass index: possible mode of function. Regul Pept (2005) 0.93
No induction of anti-viral responses in human cell lines HeLa and MCF-7 when transfecting with siRNA or siLNA. Biochem Biophys Res Commun (2006) 0.93
NotI flanking sequences: a tool for gene discovery and verification of the human genome. Nucleic Acids Res (2002) 0.92
GeneLynx mouse: integrated portal to the mouse genome. Genome Res (2003) 0.92
Locked nucleic acid containing antisense oligonucleotides enhance inhibition of HIV-1 genome dimerization and inhibit virus replication. FEBS Lett (2004) 0.92
Genomic regulation after CD40 stimulation in microglia: relevance to Alzheimer's disease. Brain Res Mol Brain Res (2005) 0.91
Association between the nociceptin receptor gene (OPRL1) single nucleotide polymorphisms and alcohol dependence. Addict Biol (2008) 0.91
Use of vivo-morpholinos for control of protein expression in the adult rat brain. J Neurosci Methods (2011) 0.91
A novel single nucleotide polymorphism of the neuropeptide Y (NPY) gene associated with alcohol dependence. Alcohol Clin Exp Res (2005) 0.91
NPY Leu7Pro and alcohol dependence in Finnish and Swedish populations. Alcohol Clin Exp Res (2003) 0.90
Functional comparison of single- and double-stranded siRNAs in mammalian cells. Biochem Biophys Res Commun (2004) 0.90
mRNA accessible site tagging (MAST): a novel high throughput method for selecting effective antisense oligonucleotides. Nucleic Acids Res (2003) 0.90
Knockdown of BACE1-AS Nonprotein-Coding Transcript Modulates Beta-Amyloid-Related Hippocampal Neurogenesis. Int J Alzheimers Dis (2011) 0.90
The Emerging Role of Non-Coding RNAs in Drug Addiction. Front Genet (2012) 0.89
A universal plasmid library encoding all permutations of small interfering RNA. Proc Natl Acad Sci U S A (2005) 0.89
Complex HTR2C linkage disequilibrium and promoter associations with body mass index and serum leptin. Hum Genet (2005) 0.89
Expression of non-protein-coding antisense RNAs in genomic regions related to autism spectrum disorders. Mol Autism (2013) 0.88
Genetics of neurological disorders. Expert Rev Mol Diagn (2004) 0.88
Mechanisms of triplex DNA-mediated inhibition of transcription initiation in cells. Biochimie (2010) 0.88
Emerging, reemerging, and forgotten brain areas of the reward circuit: Notes from the 2010 Motivational Neural Networks conference. Behav Brain Res (2011) 0.88
Diagnostic utility of APOE, soluble CD40, CD40L, and Abeta1-40 levels in plasma in Alzheimer's disease. Cytokine (2008) 0.87
Differential effects of the Gβ5-RGS7 complex on muscarinic M3 receptor-induced Ca2+ influx and release. Mol Pharmacol (2014) 0.86
RNAi screen indicates widespread biological function for human natural antisense transcripts. PLoS One (2010) 0.86
Gene characterization index: assessing the depth of gene annotation. PLoS One (2008) 0.86
Role of Sirtuin 1 in metabolic regulation. Drug Discov Today (2010) 0.85
Epigenetic pathways and glioblastoma treatment. Epigenetics (2013) 0.85
Characterization of RNA interference in rat PC12 cells: requirement of GERp95. Biochem Biophys Res Commun (2004) 0.85
Behavioural analysis of melanin-concentrating hormone in rats: evidence for orexigenic and anxiolytic properties. Regul Pept (2003) 0.84
Behavioral effects of CD40-CD40L pathway disruption in aged PSAPP mice. Brain Res (2004) 0.84
Adult neurogenesis: a potential tool for early diagnosis in Alzheimer's disease? J Alzheimers Dis (2010) 0.83
Focusing on RISC assembly in mammalian cells. Biochem Biophys Res Commun (2008) 0.83
CD40 deficiency mitigates Alzheimer's disease pathology in transgenic mouse models. J Neuroinflammation (2006) 0.82
Small RNA-directed transcriptional control: new insights into mechanisms and therapeutic applications. Cell Cycle (2010) 0.82
Calorie restriction alleviates the age-related decrease in neural progenitor cell division in the aging brain. Eur J Neurosci (2013) 0.82
Nonsynonymous SNPs: validation characteristics, derived allele frequency patterns, and suggestive evidence for natural selection. Hum Mutat (2006) 0.82
Navigating genomic maps of cancer cells. Nat Biotechnol (2010) 0.82